Immunodiagnostic Systems (IDS), a leading producer of diagnostic testing kits for the clinical and research markets, announced a trading update for the six month period to the 30 September 2010. The company reported that trading remains in line with the management’s expectations and turnover is 34% ahead of the comparative period for last year at £22.6 million (2009: £16.9 million). IDS's broker is currently forecasting an EPS of 42.5p for FY 2011.

The company continues to make progress placing instruments, at the end of September 140 iSYS machines had been placed or sold since its launch February 2009 (as at 31 March 2010: 74 iSYS machines were sold or placed).

Unlock the rest of this article with a 14 day trial

Unlock with Email
Unlock with Google

Already have an account?
Login here